This review aims to synthesize current knowledge on COL11A1 in breast cancer, focusing on its involvement in therapeutic resistance, tumor immune interactions, and its potential as a diagnostic, prognostic, or therapeutic biomarker. This evidence concerns the gene COL11A1 and neoplasm.